Exponent (EXPO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Achieved double-digit growth in revenues and earnings for Q1 2026, driven by strong demand for multidisciplinary expertise in AI-integrated consumer electronics, utilities, energy, medical devices, and construction, with both proactive and reactive client engagements.
Leadership transition announced: John Pye as President and Eric Anderson as CFO, effective May 1, 2026, with outgoing CFO remaining as EVP.
Over 50 years of multidisciplinary consulting expertise, serving high-risk, high-exposure challenges globally.
Positioned to benefit from trends in safety, health, sustainability, automation, and digital health, leveraging a diversified client base and resilient business model.
Integration of AI and advanced technologies continues to drive demand for specialized expertise.
Financial highlights
Q1 2026 total revenues rose 14% year-over-year to $166.3 million; revenues before reimbursements up 10% to $151.8 million.
Net income increased 11% to $29.6 million; diluted EPS up 13% to $0.59.
EBITDA grew 15% to $43.1 million (28.4% margin), with margin improving from 27.3% in Q1 2025.
Billable hours up 6% to 399,000; technical FTEs increased 5% to 1,013; utilization rose to 76%.
G&A expenses increased 24% to $6.2 million, mainly due to higher travel and recruiting costs.
Outlook and guidance
Q2 and full-year 2026 guidance: net revenues expected to grow high single digits year-over-year; EBITDA margin projected at 27%-28.1%.
Technical FTEs expected to grow 4%-5% for the year; utilization to remain around 72.5%-73%.
Stock-based compensation for 2026 forecasted at $27.9-$28.4 million; capital expenditures at $12-$14 million.
Management expects continued investment in talent and infrastructure, with ongoing focus on emerging growth areas and capital allocation to enhance shareholder value.
Leadership changes expected to strengthen capabilities and support long-term growth.
Latest events from Exponent
- Virtual meeting to elect directors, ratify auditor, and approve executive pay, with strong governance focus.EXPO
Proxy filing20 Apr 2026 - Strong Q4 and FY2025 results, with high single-digit growth and margin expansion expected in 2026.EXPO
Q4 202513 Apr 2026 - Q2 2024 net income up 14% on flat revenues, with raised guidance and strong sector demand.EXPO
Q2 20242 Feb 2026 - Q3 net income up 6% to $26M, margin guidance raised, and $0.28 dividend declared.EXPO
Q3 202418 Jan 2026 - Q4 and FY24 results exceeded expectations; 2025 growth to be modest amid headcount recovery.EXPO
Q4 202425 Dec 2025 - Flat Q1 revenue, lower net income, and stable 2025 outlook with rising headcount.EXPO
Q1 202523 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and executive pay, all recommended for approval.EXPO
Proxy Filing1 Dec 2025 - Q2 2025 revenues up 1%, lower margins, strong dispute-related growth, positive outlook.EXPO
Q2 202516 Nov 2025 - Q3 2025 delivered double-digit revenue growth, higher net income, and raised margin guidance.EXPO
Q3 20257 Nov 2025